Rossi Carlo Maria, Lenti Marco Vincenzo, Santacroce Giovanni, Merli Stefania, Vanoli Alessandro, Di Sabatino Antonio
Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy.
First Department of Internal Medicine, Clinica Medica I, Fondazione IRCCS Policlinico San Matteo, Università Di Pavia, Viale Golgi 19, 27100, Pavia, Italy.
Intern Emerg Med. 2025 Apr;20(3):655-665. doi: 10.1007/s11739-024-03846-7. Epub 2024 Dec 27.
Eosinophilic oesophagitis (EoE) is a chronic and progressive immune-mediated condition, typically affecting young atopic male adults and potentially leads to organ dysfunction and fibrosis. The clinical spectrum widely varies -from non-troublesome dysphagia to food impaction- and hence the rate of misdiagnosis and diagnostic delay are high, especially when presenting with minor symptoms, such as heartburn and acid regurgitation. There have been several major therapeutic breakthroughs for the management of EoE in recent years. Highly effective conventional agents with oesophagus-specific formulations (i.e. orodispersible budesonide) and a biological agent (i.e. dupilumab) now have a formal indication. Oesophageal dilation may be indicated in case of strictures, which are more common in longstanding and untreated disease. Therefore, the early diagnosis of this disorder and specialist referral is if of great importance. The evaluation of alarm signs and typical presentation patterns should allow a more straightforward recognition. The emergency and internal medicine doctors should actively be involved in this process and take part to the multidisciplinary care of patients with EoE, to allow better patient care and clinical outcomes.
嗜酸性粒细胞性食管炎(EoE)是一种慢性进行性免疫介导疾病,通常影响年轻的特应性成年男性,可能导致器官功能障碍和纤维化。临床症状范围广泛,从无明显困扰的吞咽困难到食物嵌塞,因此误诊率和诊断延迟率很高,尤其是当出现烧心和反酸等轻微症状时。近年来,EoE的治疗取得了几项重大突破。具有食管特异性制剂(即口腔崩解布地奈德)的高效传统药物和一种生物制剂(即度普利尤单抗)现在有了正式适应证。对于狭窄患者可能需要进行食管扩张,狭窄在长期未治疗的疾病中更为常见。因此,这种疾病的早期诊断和转诊至专科医生非常重要。对警示体征和典型表现模式的评估应有助于更直接地识别病情。急诊科和内科医生应积极参与这一过程,并参与EoE患者的多学科护理,以提供更好的患者护理和临床结局。